CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 44 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,832 | +602.1% | 185,000 | +825.0% | 0.00% | – |
| Q2 2023 | $30,600 | -95.1% | 20,000 | -96.1% | 0.00% | – |
| Q1 2023 | $622,850 | +8.1% | 507,000 | 0.0% | 0.00% | – |
| Q4 2022 | $575,942 | +17.5% | 507,000 | +11.7% | 0.00% | – |
| Q3 2022 | $490,000 | +716.7% | 454,000 | +808.0% | 0.00% | – |
| Q2 2022 | $60,000 | +200.0% | 50,000 | +284.6% | 0.00% | – |
| Q3 2021 | $20,000 | +300.0% | 13,000 | +333.3% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 3,000 | -25.0% | 0.00% | – |
| Q1 2021 | $7,000 | -98.2% | 4,000 | -98.6% | 0.00% | – |
| Q4 2020 | $386,000 | +26.1% | 277,000 | 0.0% | 0.00% | – |
| Q3 2020 | $306,000 | -78.8% | 277,000 | -79.9% | 0.00% | – |
| Q2 2020 | $1,445,000 | +56.2% | 1,380,000 | +38.0% | 0.00% | – |
| Q1 2020 | $925,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
| ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
| SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
| MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
| Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
| WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |